Cholestatic liver cirrhosis is the general name of the disease when the process occurs with stagnation of bile in the connective tissues of the liver. The pathological area becomes denser and functionality is impaired. This type of liver damage is characterized by a high probability of malignancy (transformation of cells into malignant ones), due to which the patient’s quality of life significantly deteriorates. Cholestatic cirrhosis of the liver is a liver disease caused by prolonged stagnation of bile acids in the bile ducts of its parenchyma. This condition occurs as a result of inflammatory liver diseases (hepatitis), autoimmune processes with liver damage, or when the outflow of bile through the bile ducts is impaired (cholestasis).
Liver cirrhosis is a chronic liver disease characterized by the degeneration of liver parenchyma into dense connective tissue with the replacement of liver cells by scar tissue and the subsequent occurrence of varying degrees of degeneration of liver function. The process, as a rule, is not accompanied by obvious symptoms and can proceed for years asymptomatically or with few symptoms.